Is there a generic for Aspirin; caffeine; orphenadrine citrate?

Yes. The FDA Orange Book lists 4 approved generic (ANDA) applications for Aspirin; caffeine; orphenadrine citrate, referencing the brand NORGESIC. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Aspirin; caffeine; orphenadrine citrate?

NORGESIC (NDA 013416, BAUSCH) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Aspirin; caffeine; orphenadrine citrate are approved?

Aspirin; caffeine; orphenadrine citrate is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Aspirin; caffeine; orphenadrine citrate

Aspirin; caffeine; orphenadrine citrate is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:NORGESIC · NDA 013416

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
NORGESICRLD×2	BAUSCH	NDA 013416	—	Oct 27, 1982

Generic (ANDA) products (4)

Product	Applicant	Application	TE	Approved
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE×2	STEVENS J	ANDA 074988	—	Apr 30, 1999
ORPHENGESIC×2	GALT PHARMS	ANDA 075141	—	May 29, 1998
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE×2	SANDOZ	ANDA 074654	—	Dec 31, 1996
INVAGESIC×2	CHARTWELL RX	ANDA 074817	—	Nov 27, 1996

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Aspirin; caffeine; orphenadrine citrate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo